BIOCOM Interrelations GmbH 29. August 2018

EFIB is the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy

EuropaBio and its local partner Toulouse White Biotech cordially invite you to add the 2018 edition of EFIB to your calendar and join the mailing list to be notified of when registrations open. The forum will be hosted in the Centre de Congrès Pierre Baudis in Toulouse from 16 to 18 of October.



Industrial Biotechnology is currently worth €23 billion representing just 6% in sales of the overall worldwide chemicals market. However, it is significantly out-performing the overall chemicals market at an impressive 20% annual growth rate and has the potential to become the dominant technology of tomorrow’s chemicals industry, representing a huge future opportunity.


Delivering on this opportunity will require significant investment, innovation and value chain development and most importantly new collaborations across the sector. Additionally we are faced with important challenges posed by high energy prices, the impact of the shale gas boom on the development of biobased chemicals markets and the ongoing need for predictable, coherent and supportive policy in the EU.


In order to understand and overcome these challenges and prosper in the industrial biotechnology market, industry experts throughout the vibrant and innovative biobased community come together to one central location every year to discuss the key issues and gain a snapshot of the most significant developments on scale up of commercial biorefineries around the world.


That location is the European Forum for Industrial Biotechnology & the Bioeconomy (EFIB), where delegates are provided with an update on the status and outlook of biobased industries. EFIB is proud to foster engagement between policy makers, a broad range of stakeholders connected with the existing biobased value chain and seeks to reach out to, and include, new interlocutors.


For further information please click here.

Unternehmen
BIOCOM ist überall dort erfolgreich, wo die Life Sciences spezialisierte Organisations- und Kommunikationsprozesse erfordern. Durch d... [mehr]